持仓播报:二季度基金“吃药”效果好 看看吃的什么“药”

2012-08-06 15:59:00 易天富基金网

  编者按截至上周五披露的21家医药生物企业在扣除非经常性损益后,除海普瑞  一家外,净利全实现正增长。从目前披露的半年报来看,基金二季度提前布局,“吃药”劲头十足。以下是中国资本证券网整理的二季度基金“吃药”情况,供者参考。

  证券代码证券简称基金持股数社保基金持股数七月涨跌幅

  300026.SZ红日药业24,402,795.0000-17.4854

  300016.SZ北陆药业7,486,686.0000-14.5833

  002004.SZ华邦制药19,145,956.00003,157,504.000012.4444

  300039.SZ上海凯宝14,214,821.0000-12.1076

  600436.SH片仔癀6,471,910.00003,806,002.000011.9354

  000566.SZ海南海药58,521,455.0000-8.1293

  600332.SH广州药业1,414,219.0000-6.8063

  600196.SH复星医药49,584,915.000013,189,126.00006.2076

  000919.SZ金陵药业19,192,517.000023,109,247.00006.1478

  600535.SH天士力72,988,316.0000-4.9863

  000522.SZ白云山A12,539,398.0000-4.2281

  000989.SZ九芝堂24,077,064.0000-3.7037

  002390.SZ信邦制药479,902.0000-2.1870

  600252.SH中恒集团67,526,030.00003,969,295.00002.0073

  600557.SH康缘药业64,454,554.0000-1.8268

  600867.SH通化东宝16,376,654.0000-1.6688

  601607.SH上海医药71,901,228.0000-0.9054

  002370.SZ亚太药业337,227.0000-0.6993

  300199.SZ翰宇药业5,210,664.00001,358,177.00000.2556

  (李正)